Active Substances from the Micro-Immunotherapy Medicine 2LC1(®) Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages.

微免疫疗法药物 2LC1(®) 中的活性物质在结肠癌、前列腺癌和乳腺癌模型中显示出体外抗癌特性，并在人类巨噬细胞中显示出免疫增强能力